Skip main navigation
Basic Science
Cardiac and Vascular Signaling

Abstract 1212: Insulin-like Growth Factor-I Reduces Inflammatory Responses, Suppresses Oxidative Stress and Decreases Atherosclerosis Progression in ApoE-deficient Mice

Originally publishedCirculation. 2007;116:II_246

    Atherosclerosis is a chronic inflammatory disease of the vasculature that is responsible for most cardiovascular disease-related death. We have previously shown that expression of insulin-like growth factor-1 (IGF-1) and its receptor is reduced in areas of advanced human plaque staining positive for oxidized LDL suggesting that decreased IGF-1 activity could contribute to disease development and/or progression. To investigate the potential role of IGF-1 in atherogenesis we infused recombinant human IGF-1 (1.5 mg/kg/day) in 8 week old ApoE-deficient mice on a Western diet. IGF-1 infusion (for 12 weeks) doubled circulating IGF-1 levels compared with saline control (665 ± 93 vs. 283 ± 8 ng/ml) but did not change body weight or total cholesterol levels. IGF-1 infused mice had a 27% reduction in atherosclerotic lesion size compared to control (0.259 ± 0.018 mm2 vs. 0.356 ± 0.031 mm2, P<0.01) as quantified using aortic valve sections. This decrease correlated with a 36% decrease in plaque macrophage infiltration (0.050 ± 0.003 mm2 vs. 0.078 ± 0.007 mm2, P<0.01; immunostaining with Mac-3 antibody), a 39% reduction in urine 8-isoprostane levels (an index of systemic oxidative stress) (2.0 ± 0.3 vs. 3.3 ± 0.3 ng/mg creatinine, P<0.01) and a marked decrease in aortic superoxides (85% decrease compared to control, P<0.001, DHE-stained frozen sections with/without pretreatment with superoxide scavenger PEG-SOD). IGF-1 reduced aortic mRNA levels of the proinflammatory cytokines IL-6 and TNF-α, by 2.9-fold and 4.2-fold, respectively, without changing serum levels. Furthermore, IGF-1 upregulated aortic eNOS expression by 4.4-fold (real-time PCR) and increased levels of circulating endothelial progenitor cells (EPC) (3.58 ± 0.82 %, IGF-1, vs. 1.61 ± 0.42 %, control, P=0.06, FACS analysis for Sca-1+/Flk-1+ cells), suggesting that IGF-1 promotes vascular repair. In summary, IGF-1 markedly suppresses systemic and vascular oxidant stress and reduces atherosclerosis progression in ApoE-deficient mice. The finding that IGF-1 has antioxidant and anti-atherogenic properties establish a new paradigm for biological effects of IGF-1 and has major implications for treating atherosclerosis and its complications.


    eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.

    Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.